Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has disclosed the outcomes of its 65th Annual General Meeting held on August 22, 2025. Shareholders approved the reappointment of Mr. Bharat Nemchand Shah and Mr. Gaurav Satish Shah as Non-Executive Non-Independent Directors liable to retire by rotation. Mr. Ankit Kishor Chande was reappointed as Cost Auditor for FY 2025-26, while M/s. GHV & Co. was appointed as Secretarial Auditor for a five-year term covering FY 2025-26 to FY 2029-30. Additionally, Mr. Ritesh Shah and Mr. Vivek Shah were reappointed as Joint Managing Directors for five years effective January 8, 2026, until January 7, 2031.
This is a routine governance announcement with no material impact on shareholders. Leadership continuity is maintained, with the promoter-family Shah brothers (Ritesh and Vivek) continuing as JMDs and the cost and secretarial audit functions being secured for the coming years.